Search research articles
Contact Us
Filters
Showing results (11-20 of 442) with videos related to
Page
of 45
Sort By:
Stem Cells International
|
June 14, 2019
Prognostic Factors for Clinical Response in Systemic Lupus Erythematosus Patients Treated by Allogeneic Mesenchymal Stem Cells
Lihui Wen, Myriam Labopin, Manuela Badoglio, et al.
Haematologica
|
August 30, 2012
Impact of FLT3 ITD/NPM1 mutation status in adult patients with acute myelocytic leukemia autografted in first remission
Norbert-Claude Gorin, Myriam Labopin, Giovanna Meloni, et al.
Haematologica
|
February 3, 2004
Comparison of BAVC to BuCy regimens in autologous stem cell transplantation for adult patients with acute myeloid leukemia
Loïc Fouillard, Myriam Labopin, Giovanna Meloni, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 17, 2002
Dose-effect relationship for cataract induction after single-dose total body irradiation and bone marrow transplantation for acute leukemia
M Loes van Kempen-Harteveld, Yazid Belkacémi, Henk B Kal, et al.
Blood
|
August 19, 2010
Reduced-intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation
Mohamad Mohty, Myriam Labopin, Liisa Volin, et al.
Cancer
|
November 27, 2014
Reduced-intensity conditioning with fludarabine and busulfan versus fludarabine and melphalan for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
Frédéric Baron, Myriam Labopin, Andy Peniket, et al.
Bone Marrow Transplantation
|
August 14, 2024
ATG and other serotherapy in conditioning regimens for autologous HSCT in autoimmune diseases: a survey on behalf of the EBMT Autoimmune Diseases Working Party (ADWP)
Azza Ismail, Rosamaria Nitti, Basil Sharrack, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 12, 2013
Improving results of autologous stem cell transplantation for Philadelphia-positive acute lymphoblastic leukaemia in the era of tyrosine kinase inhibitors: a report from the Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation
Sebastian Giebel, Myriam Labopin, Norbert Claude Gorin, et al.
Bone Marrow Transplantation
|
November 7, 2024
Monitoring and management of CMV and EBV after autologous haematopoietic stem cell transplantation for autoimmune diseases: a survey of the EBMT Autoimmune Diseases Working party (ADWP)
Tobias Alexander, Manuela Badoglio, Myriam Labopin, et al.
Bone Marrow Transplantation
|
August 23, 2019
Features of Toxoplasma gondii reactivation after allogeneic hematopoietic stem-cell transplantation in a high seroprevalence setting
Olivier Paccoud, Juliette Guitard, Myriam Labopin, et al.
Page
of 45
Search research articles
Search
Showing results (11-20 of 442) with videos related to
Sort By:
Page
of 45
Stem Cells International
|
June 14, 2019
Prognostic Factors for Clinical Response in Systemic Lupus Erythematosus Patients Treated by Allogeneic Mesenchymal Stem Cells
Lihui Wen, Myriam Labopin, Manuela Badoglio, et al.
Haematologica
|
August 30, 2012
Impact of FLT3 ITD/NPM1 mutation status in adult patients with acute myelocytic leukemia autografted in first remission
Norbert-Claude Gorin, Myriam Labopin, Giovanna Meloni, et al.
Haematologica
|
February 3, 2004
Comparison of BAVC to BuCy regimens in autologous stem cell transplantation for adult patients with acute myeloid leukemia
Loïc Fouillard, Myriam Labopin, Giovanna Meloni, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 17, 2002
Dose-effect relationship for cataract induction after single-dose total body irradiation and bone marrow transplantation for acute leukemia
M Loes van Kempen-Harteveld, Yazid Belkacémi, Henk B Kal, et al.
Blood
|
August 19, 2010
Reduced-intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation
Mohamad Mohty, Myriam Labopin, Liisa Volin, et al.
Cancer
|
November 27, 2014
Reduced-intensity conditioning with fludarabine and busulfan versus fludarabine and melphalan for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
Frédéric Baron, Myriam Labopin, Andy Peniket, et al.
Bone Marrow Transplantation
|
August 14, 2024
ATG and other serotherapy in conditioning regimens for autologous HSCT in autoimmune diseases: a survey on behalf of the EBMT Autoimmune Diseases Working Party (ADWP)
Azza Ismail, Rosamaria Nitti, Basil Sharrack, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 12, 2013
Improving results of autologous stem cell transplantation for Philadelphia-positive acute lymphoblastic leukaemia in the era of tyrosine kinase inhibitors: a report from the Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation
Sebastian Giebel, Myriam Labopin, Norbert Claude Gorin, et al.
Bone Marrow Transplantation
|
November 7, 2024
Monitoring and management of CMV and EBV after autologous haematopoietic stem cell transplantation for autoimmune diseases: a survey of the EBMT Autoimmune Diseases Working party (ADWP)
Tobias Alexander, Manuela Badoglio, Myriam Labopin, et al.
Bone Marrow Transplantation
|
August 23, 2019
Features of Toxoplasma gondii reactivation after allogeneic hematopoietic stem-cell transplantation in a high seroprevalence setting
Olivier Paccoud, Juliette Guitard, Myriam Labopin, et al.
Page
of 45